Surrogacy of Time to Progression for Overall Survival in Advanced Hepatocellular Carcinoma Treated with Systemic Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Time to progression (TTP) is widely used as the endpoint in early-phase trials of advanced hepatocellular carcinoma (HCC). However, the relevance of using TTP as a surrogate marker for overall survival (OS) in pivotal trials remains uncertain. The PubMed database and ASCO Meeting Library were search...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Liver Cancer
Autors principals: Terashima, Takeshi, Yamashita, Tatsuya, Toyama, Tadashi, Arai, Kuniaki, Kawaguchi, Kazunori, Kitamura, Kazuya, Yamashita, Taro, Sakai, Yoshio, Mizukoshi, Eishiro, Honda, Masao, Kaneko, Shuichi
Format: Artigo
Idioma:Inglês
Publicat: S. Karger AG 2019
Matèries:
Original Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6465721/
https://ncbi.nlm.nih.gov/pubmed/31019903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000489505
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars